Beyond Air Soars 5.42% on Premier Contract

Generated by AI AgentAinvest Pre-Market Radar
Tuesday, Jul 22, 2025 7:50 am ET1min read
Aime RobotAime Summary

- Beyond Air's stock jumped 5.42% pre-market after securing a Premier, Inc. contract covering two-thirds of U.S. hospitals.

- The deal accelerates adoption of its cylinder-free nitric oxide system to enhance hospital efficiency and patient outcomes.

- FDA medical device designation for LungFit validates the company's innovative approach to critical healthcare solutions.

On July 22, 2025, Beyond Air's stock surged by 5.42% in pre-market trading, marking a significant rise that has caught the attention of investors and analysts alike.

Beyond Air has secured a premier contract with Premier, Inc., granting the company access to two-thirds of the U.S. hospital market. This agreement is expected to streamline the adoption process for Beyond Air's innovative cylinder-free nitric oxide system, which is designed to improve patient outcomes and operational efficiency in hospitals.

Beyond Air's LungFit, a cylinder-free, phasic flow generator and delivery system, has been designated as a medical device by the U.S. Food and Drug Administration (FDA). This designation underscores the company's commitment to developing cutting-edge medical technologies that address critical healthcare needs.

Comments



Add a public comment...
No comments

No comments yet